4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-008556
CHIEF EXECUTIVE OFFICER sold 27,279 shares at $44.21 ($1,206,122)
- CHIEF EXECUTIVE OFFICER acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-15 | Option exercise | +50,000 | 165,920 | D | ||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-17 | Sale | −27,279 | $44.21 | $1,206,122 | 138,641 | D |
| Derivatives | |||||||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-15 | Option exercise · Performance Restricted Stock Units | −50,000 | 25,000 | D | ||
| Open-market sales · 27,279 sh · avg $44.21 · $1,206,122 | |||||||
Loading xslF345X05/form4-03182025_090301.xml…